Because of the emerging intersections of HIV infection and Alzheimer's disease, we examined cerebrospinal fluid (CSF) biomarkers related of amyloid and tau metabolism in HIV-infected patients. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.